Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.83
-0.41 (-4.44%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $462.28 million as of July 13, 2026. Its market cap has increased by 38.95% in one year.
Market Cap
462.28M
Enterprise Value
140.47M
1-Year Change
38.95%
Ranking
Category
Stock Price
$8.83
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $462.28M, an increase of 263.14%. That is a compound annual growth rate of 9.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 462.28M | -10.08% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
| Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 497.63M |
| Rezolute | 496.22M |
| Sutro Biopharma | 492.64M |
| Verastem | 485.94M |
| Zura Bio | 485.44M |
| Cabaletta Bio | 485.09M |
| Prelude Therapeutics | 476.55M |
| Evommune | 475.80M |